Good evening :)

How to use scorecard? Learn more

AMC Logo

ITI Pharma & Healthcare Fund Direct Growth

Growth
₹20.100.35% (-0.07)
High
—
—
Low
—
—
Returns
—
—
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Small-size Fund

Assets Under Mgmt: ₹ 276 Cr

Very High Risk

Principle investment will be at very high risk

Scorecard

Performance

Low

Hasn’t fared well - amongst the low performers in sub-category

Risk

High

Stay alerted, risk is higher vs others

Cost

Avg

Market standard costs, nothing exciting

Composition

Low

Composition not as great as others

Red flags

Low

We got you covered, no major red flags identified

How to use scorecard? Learn more

Small-size Fund

Assets Under Mgmt: ₹ 276 Cr

Very High Risk

Principle investment will be at very high risk

ITI Pharma & Healthcare Fund Performance & Key Metrics

ITI Pharma & Healthcare Fund Performance & Key Metrics

No LabelNo LabelBase Expense RatioBase Exp. RatioNo LabelNo Label
0.920.581.04
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.741.1149.86

ITI Pharma & Healthcare Fund Scheme InfoITI Pharma & Healthcare Fund Scheme Info

PlanPlanLock inLock in
Lock in Period

Period before which your investment can't be withdrawn from the MF scheme

Exit LoadExit Load
Exit Load

The fee that the AMC charges investors at the time of exiting or redeeming their fund units.

Growth0 yrs0.50%
0.50% on or before 3M NIL after 3M
SIP Inv.SIP Inv.
Sip Investment

If SIP investments are allowed in the fund or not

Min. LumpsumMin. Lumpsum
Minimum Lumpsum Inv Amount

Minimum investment the AMC allows in the given scheme via lumpsum route

Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
Benchmark Index

Benchmark index wrt which performance of the fund is tracked

Nifty Healthcare Index - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

ITI Pharma & Healthcare Fund Peers

ITI Pharma & Healthcare Fund Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care
Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
ITI Pharma & Healthcare Fund15.21%21.33%15.37%
Nippon India Pharma Fund13.71%19.70%17.57%
ICICI Pru Healthcare Fund9.34%23.19%20.77%
SBI Healthcare Opp Fund23.13%24.94%18.28%

ITI Pharma & Healthcare Fund Returns Comparison

Compare ITI Pharma & Healthcare Fund with any MF, ETF, stock or index
Compare ITI Pharma & Healthcare Fund with any MF, ETF, stock or index
ITI Pharma & Healthcare Fund
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

ITI Pharma & Healthcare Fund Portfolio

ITI Pharma & Healthcare Fund Asset Allocation

ITI Pharma & Healthcare Fund Asset Allocation

Actual

Target

Dec 2025

Mar 2026

Jun 2026

Aug 2026

ACTUAL
Cash & EquivalentsEquity0.71%99.29%

Dec 2025

Mar 2026

Jun 2026

Aug 2026

Tickertape Separator

ITI Pharma & Healthcare Fund Sector Distribution

ITI Pharma & Healthcare Fund Sector Distribution

+1 morePlastic ProductsOthersHealth Care Equipment & SuppliesLabs & Life Sciences ServicesPharmaceuticals0.99 %1.25 %1.31 %1.50 %22.10 %72.85 %

Dec 2025

Mar 2026

Jun 2026

Aug 2026

Tickertape Separator

ITI Pharma & Healthcare Fund Sector Weightage

ITI Pharma & Healthcare Fund Sector Weightage

Jun 25Sep 25Dec 25Mar 26Jun 26Aug 2669.49%67.33%69.76%70.10%70.40%72.85%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

ITI Pharma & Healthcare Fund Current Holdings

ITI Pharma & Healthcare Fund Current Holdings

Equity

Others

Sort holdings
  • Constituent
    Holding Weight
    3M Change

AMC Profile of ITI Pharma & Healthcare Fund

AMC Profile of ITI Pharma & Healthcare Fund

ITI Asset Management Holding Ltd. operates as a buy-side intermediation, advisory and asset management business in Emerging and Global Markets. It provides clients access to alternative investments, ETFs and other products of a different risk levels and investment horizons.

ITI Asset Management Holding Ltd. operates as a buy-side intermediation, advisory and asset management business in Emerging and Global Markets. It provides clients access to alternative investments, ETFs and other products of a different risk levels and investment horizons.

  • No.of Schemes

    21

  • Total AUM

    ₹ 12,612.66 Cr.

ITI Pharma & Healthcare Fund Manager Details

ITI Pharma & Healthcare Fund Manager Details

ITI Pharma & Healthcare Fund Manager Profile

ITI Pharma & Healthcare Fund Manager Profile

ITI Pharma & Healthcare Fund Manager Performance (0)

ITI Pharma & Healthcare Fund Manager Performance (0)

Loading...

ITI Pharma & Healthcare Fund Review & Opinions

ITI Pharma & Healthcare Fund Review & Opinions

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
Hmm, looks like data is unavailable here. Please come back after some time.

Frequently asked questions

  1. The current NAV of ITI Pharma & Healthcare Fund is ₹20.10, as of 25th September 2026.

  2. The ITI Pharma & Healthcare Fund was launched on 8th November 2021. This mutual fund's past returns are as follows:
    • 1 Year Returns: 15.21%
    • 3 Year Returns: 21.33%

  3. The top sectors ITI Pharma & Healthcare Fund has invested in are as follows:
    • Pharmaceuticals | 72.85%
    • Labs & Life Sciences Services | 22.10%
    • Health Care Equipment & Supplies | 1.50%
    • Others | 1.31%
    • Plastic Products | 1.25%
    This data is as on 25th September 2026.

  4. The top 5 holdings for ITI Pharma & Healthcare Fund are as follows:
    • Sun Pharmaceutical Industries Ltd | 12.58%
    • Divi's Laboratories Ltd | 9.23%
    • Apollo Hospitals Enterprise Limited | 5.72%
    • Max Healthcare Institute Limited | 4.84%
    • Torrent Pharmaceuticals Ltd | 4.75%
    This data is as on 25th September 2026.

  5. The asset allocation for ITI Pharma & Healthcare Fund is as follows:
    • Equity | 99.29%
    • Cash & Equivalents | 0.71%
    This data is as on 25th September 2026.

  6. The AUM (i.e. assets under management) of ITI Pharma & Healthcare Fund is ₹276.23 Cr as of 25th September 2026.

  7. The base expense ratio of ITI Pharma & Healthcare Fund Plan is 0.58 as of 25th September 2026.

  8. The alpha ratio for the ITI Pharma & Healthcare Fund is -0.04

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. The volatility or standard deviation for the ITI Pharma & Healthcare Fund is 12.93

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. The Sharpe ratio for the ITI Pharma & Healthcare Fund is 1.04

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. The Sortino Ratio for the ITI Pharma & Healthcare Fund is 0.12

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. The PE ratio of ITI Pharma & Healthcare Fund is 49.86, while category PE ratio is 47.73.